CAS 780758-10-3
:Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 produtos.
Nimotuzumab
CAS:<p>Intereferes with EGFR ligand binding; cancer therapy</p>Pureza:Min. 95%Cor e Forma:Clear LiquidNimotuzumab (powder)
CAS:<p>Nimotuzumab (powder) is a humanized IgG1 monoclonal antibody that specifically targets the epidermal growth factor receptor (EGFR), possessing a dissociation constant (KD) of 0.21 nM. It blocks the binding to its ligand by targeting the extracellular domain of EGFR. Nimotuzumab exhibits strong antitumor activity by inducing both antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC), exerting cytolytic effects on target tumors.</p>Cor e Forma:Liquid
